Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy

Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

(2016) Marc Mendelson et al.   LANCET

Access to effective antimicrobials: a worldwide challenge

(2016) Ramanan Laxminarayan et al.   LANCET

International cooperation to improve access to and sustain effectiveness of antimicrobials

(2016) Christine Årdal et al.   LANCET

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach

(2016) John H Rex et al.   LANCET INFECTIOUS DISEASES

An international legal framework to address antimicrobial resistance

(2015) Steven J Hoffman et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Repairing The Broken Market For Antibiotic Innovation

(2015) Kevin Outterson et al.   HEALTH AFFAIRS

Experience With the Priority Review Voucher Program for Drug Development

(2015) Aaron S. Kesselheim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Universal Access to Effective Antibiotics is Essential for Tackling Antibiotic Resistance

(2015) Nils Daulaire et al.   JOURNAL OF LAW MEDICINE & ETHICS

What Will it Take to Address the Global Threat of Antibiotic Resistance?

(2015) Steven J. Hoffman et al.   JOURNAL OF LAW MEDICINE & ETHICS

An Empirical Review of Major Legislation Affecting Drug Development: Past Experiences, Effects, and Unintended Consequences

(2011) AARON S. KESSELHEIM   MILBANK QUARTERLY

Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals

(2010) Aaron S. Kesselheim et al.   HEALTH AFFAIRS

Antibiotic resistance and antibiotic development

(2008) Brad Spellberg   LANCET INFECTIOUS DISEASES